Becoming part of the TusPark innovation ecosystem will not only give you access to excellent workspaces and amenities, but also a range of services to advise and support the development of your venture both in the UK and China. If access to the Chinese market/investment is high on your agenda we are best placed to help you achieve that goal.
We are passionate about working with early-stage companies, advising on positioning and market entry to China. We provide physical office spaces and facilitate valuable network introductions locally. Our workspaces in the UK are also uniquely equipped, such as the Industry 4.0 Makerspace in Newcastle, and the Bio Innovation Centre in Cambridge. In addition, we work with high-level collaborators in China and the UK to run start-up competitions which provides opportunities for founders to start to understand the Chinese market, through visiting and interacting inside China, in person. We also give practical advice and things to consider when moving your start-up to China, such as data security, GDPR, intellectual property, business culture, and more.
If you’re a business looking to expand into the Chinese market, or an organisation helping scale-ups to do the same, we can help. Our Accelerator Programmes enable access to China and as the largest innovation ecosystem in China we are able to help find joint ventures and supply chain partners for companies wishing to enter the Chinese market. We can also introduce businesses to the Chinese government, and apply on their behalf for financial support and favourable policies in China. We also provide a range of financial services, including investments and Chinese investor networking, both in the UK and in China.
We bring value to our cross-border investees through a series of steps starting with an assessment of the opportunity before defining market entry strategy and supporting the creation of a local office, joint venture or M&A opportunity. Once in place we leverage the TUS network to support and develop the business locally with the aim of achieving organic growth, IPO or acquisition.
An extension of TusPark Cambridge, our China-UK Innovation Centre builds a bridge for China-UK science and technology innovation exchange.
It provides authoritative resources for businesses, advising them with personalised, integrated plans for multinational development, and builds an effective and unique platform between UK and Chinese entrepreneurs, innovators, and collaborators. It focuses on the high-value sectors: life sciences, artificial intelligence, new energy, new materials, and other high-tech fields, and aims to help innovative companies thrive internationally. Working closely with local governments and commercial partners - all experts in finance, law, IT and other related areas – the Centre is directed by the Beijing Science and Technology Commission, and helps the high-tech enterprises in the UK apply for relevant subsidies and other preferential policies from local government.
With facilities in Cambridge and Newcastle, we enable UK-based companies to connect, collaborate and build relationships with like-minded investors and innovators in China. Explore our facilities below:
In a unique partnership with Trinity College, University of Cambridge and Cambridge Science park we have invested £200m across five buildings, including the Park’s first Bio-Innovation Centre. This investment puts us at the heart of the thriving technology and innovation sector in this world-leading city.
Home to Barclays Eagle Labs, our Newcastle space provides both co-working spaces and support for start-up including free networking events, seminars and access to legal, accounting and intellectual property support teams to facilitate growth.
As a holding corporation managing assets valued over US$30 Billion and a controlling shareholder/shareholder of over 800 enterprises, our parent company, TUS Holdings has established the world’s largest global innovations ecosystem with over 300 innovation bases that have incubated over 10,000 enterprises. As such we are uniquely positioned to enable access to investment and funding for enterprises across a range of industry sectors. Discover more here…
Mogrify Limited (Mogrify®), a biopharmaceutical company located in Bio-Innovation Centre, announced today an additional $10 million USD closing of its Series A financing, bringing the total raised to $46 million USD in this round. The funding will support further advancement of Mogrify’s pipeline of in vivo reprogramming therapies through pre-clinical translation, continued platform optimization, and facilitation of new and existing biopharma collaborations.Read More
We are delighted to be partnering with KPMG and Growth Works to jointly organise a workshop on fund raising, inviting Salvatore Di Maggio, Senior Manager of Growth Business at KPMG to discuss how to Find Your Way to Funding and Getting Investors Ready.Read More